News Category
The UK's MHRA has mandated new antidepressant safety measures, including all-age suicide risk warnings and recognition of Post-SSRI Sexual Dysfunction...
Helus Pharma's reaffirmed fourth-quarter 2026 topline readout for its Phase 3 depression candidate HLP003 and a planned 2027 Phase 2 anxiety study of ...
A new analysis of 34 Asian countries shows ADHD-related disability is concentrated in early adolescence, peaking at ages 10–14, with East Asia carryin...
A psychologist's new book chapter examines how children adopted or born after a sibling's death can be burdened by unresolved parental grief, and why ...
A new WHO guide warns that institutional psychiatric treatment often violates human rights, prompting CCHR to demand that U.S. states adopt rights-bas...
Helus Pharma has appointed Dr. Suresh Durgam, a veteran CNS drug developer, to its board of directors to support the advancement of its late-stage pip...
Becky Parry's new book, Healing from Psychosis: We Are Living in a Simulation, offers a personal account of psychosis and spiritual awakening, urging ...
As more Americans turn to AI chatbots for emotional support, a Brooklyn psychologist cautions that these tools offer one-sided advice that can harm co...
Citizens Commission on Human Rights International opposes FDA approval of psychedelic drugs for mental disorders, warning of serious adverse effects a...
Helus Pharma will host an investor presentation on October 21, 2026, to highlight its Phase 3 and Phase 2 programs for major depressive disorder and g...
Dr. Judith A. Swack, originator of the Healing from the Body Level Up methodology, explains why people remain stuck in old emotional patterns and offe...
A new longitudinal study of over 1,000 adolescents shows that improvements from wilderness therapy and residential treatment can last up to 6.5 years,...
Author and mental health advocate Lawyer Johnson is offering 100 Kindle copies of his memoir 'My Pain Is My Identity' through a Goodreads giveaway, hi...
The September 2026 Wellness Index Report highlights a growing consumer demand for integrated care that connects mental, hormonal, and circulatory heal...
As Mental Health Awareness Week highlights mental well-being, CCHR International releases an updated human rights declaration and urges Americans to s...
Becky Parry's new book, Healing from Psychosis: We Are Living in a Simulation, offers a candid diary-style account of her journey through psychosis, c...
Helus Pharma's legal name change from Cybin Inc. marks a strategic pivot toward commercialization as it advances late-stage psychedelic-inspired treat...
Nashville Concierge Medicines has published a blog post addressing perimenopause and loneliness, highlighting the importance of personalized care from...
Nashville Concierge Medicine's new content explains how adult ADHD can disrupt sleep and daily focus, urging evaluation and physician consultation.
A Nevada coroner's toxicology report found multiple psychiatric drugs in a mother who killed her daughter, prompting CCHR to call for mandatory testin...
Nicole Messick's appearance on the Love Stories podcast highlights the growing movement to destigmatize intimacy wellness through education, coaching,...
Becky Parry's new book, Healing from Psychosis: We Are Living in a Simulation, offers a raw diary account of her journey through psychosis and recover...
Dr. Amar Surdhar, founder of Clarion Psychiatry, has announced his support for the HAS Foundation, highlighting the need for science, innovation, and ...
The Pennsylvania Association of Addiction Professionals will host its 2026 Annual Conference, bringing together state leaders and national experts to ...
Author and motivational speaker Lawyer Johnson will release his second book, 'People Like Us Don't Heal Normally: Every Trigger Has a Birthplace,' on ...
Helus Pharma Inc. shareholders voted to change the company's legal name from Cybin Inc. and elected eight directors at the annual and special meeting,...
Helus Pharma's CEO Michael Halstead will participate in a fireside chat at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit, highlig...
Veronica Ramos Clark's new book, A Fresh Start: Breaking the Cycle, offers memoir and practical guidance for adults raised in alcoholic or dysfunction...
Blue Ridge Therapeutic Wilderness is calling for early recognition of teen academic avoidance and school refusal, warning that these behaviors often s...
Rikki Jo Neyer's new book, Do You Believe in Miracles?, recounts her mother's eight-and-a-half-year struggle with an undiagnosed illness, the eventual...
Silo Pharma receives a Notice of Allowance from the USPTO for a patent covering its intranasal PTSD treatment SPC-15, strengthening its intellectual p...
CCHR warns parents to seek independent information before agreeing to psychiatric drugs or hospitalization for their children, citing risks of abuse a...
The Citizens Commission on Human Rights reports that the late Dr. Thomas Szasz's decades-long campaign against involuntary psychiatric hospitalization...
Families Rights Matter² has published a new article arguing that rigid privacy laws prevent families from sharing critical information during postpart...
Dr. Marilyn Puder-York, a veteran psychologist and former Citigroup VP, argues that organizations rarely become healthier than the people who lead the...
A former Blue Ridge Therapeutic Wilderness student has returned as field staff, highlighting the program's role in a broader mental health journey and...
As 39 states and Washington, D.C. restrict student cellphone use, child mental health expert Dr. Roseann Capanna-Hodge argues that the real test for f...
Volunteers with the Hubbard Dianetics Foundation of Minnesota conducted a two-week outreach across the Twin Cities, offering free stress tests and res...
Janie’s Art Journals will present a new series of handmade journals at Salud Chicago’s inaugural gala, highlighting community resilience and supportin...
HITN Media's Spanish-language townhall 'Los niños y el tiempo en pantalla' offers expert guidance on healthy screen time for preschoolers, addressing ...
Quantum BioPharma has received FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis drug that aims to protect and ...
Optimi Health Corp. will initiate a Health Canada-authorized Phase 2 clinical trial in 2027 to evaluate psilocybin-assisted therapy for major depressi...
Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, drawing attention to the compan...
The American Stroke Association's 2026 guideline stresses that stroke rehabilitation should start within 48 hours and continue indefinitely, focusing ...
Silo Pharma's participation in the IPAC-RS 2026 Nasal Innovation Forum highlights progress in its nose-to-brain drug delivery platform, with new stabi...
Helus Pharma's CEO participation in a major investment conference underscores the company's progress in developing novel treatments for depression and...
Synbio International's exclusive licensing agreement with MD PHD Wellness provides immediate access to proprietary nutraceutical products, acceleratin...
The Citizens Commission on Human Rights calls for more thorough disclosure and informed consent regarding psychotropic drugs' potential violent and su...
